Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: MIT Libraries

Online First

July 13, 2019

Correspondence
Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Humby et al
Free

Maya H Buch, Andrew Melville, Dennis G McGonagle

doi: 10.1136/annrheumdis-2019-215881
Correspondence response
Response to ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Humby et al
Free

Frances Humby, Myles Lewis, Michael J Townsend, Costantino Pitzalis

doi: 10.1136/annrheumdis-2019-215903

July 12, 2019

Recommendation
2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis
Free

Bianca Bech, Jette Primdahl, Astrid van Tubergen, Marieke Voshaar, Heidi A Zangi, Lurdes Barbosa, Carina Boström, Boryana Boteva, Francesco Carubbi, Françoise Fayet, Ricardo J O Ferreira, Kirsten Hoeper, Agnes Kocher, Marja Leena Kukkurainen, Vivienne Lion, Patricia Minnock, Antonella Moretti, Mwidimi Ndosi, Milena Pavic Nikolic, Michael Schirmer, Hana Smucrova, Jenny de la Torre-Aboki, Jennifer Waite-Jones, Yvonne van Eijk-Hustings

doi: 10.1136/annrheumdis-2019-215458
Correspondence
Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-215982
Correspondence
Ultrasonographic salivary gland evaluation in systemic sclerosis: is sicca syndrome secondary to an authentic overlap syndrome or another specific fibrotic manifestation of the disease?
Free

Guillaume Coiffier, Sandrine Jousse-Joulin, Divi Cornec, Ronan Garlantézec, Aurore Bleuzen, Elisabeth Diot, Patrick Jego, Alice Ballerie, Alain Lescoat

doi: 10.1136/annrheumdis-2019-215972

July 11, 2019

Correspondence response
Response to: ‘Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine’ by Michaud et al
Free

Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215817
Correspondence
On using machine learning algorithms to define clinically meaningful patient subgroups
Free

Rachel Knevel, Tom WJ Huizinga

doi: 10.1136/annrheumdis-2019-215959

July 08, 2019

Correspondence response
Mortality has improved in RA, but we must remain vigilant. Response to: ‘Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA’ by Matthijssen et al
Free

Pomme B M Poppelaars, Lilian H D van Tuyl, Maarten Boers

doi: 10.1136/annrheumdis-2019-215863
Correspondence response
Response to: ‘Achieving lupus low disease activity and remission states under belimumab in refractory systemic lupuserythematosus: time and organ involvement matter’ by Sbeih et al
Free

Mandana Nikpour, Molla Huq, Shereen Oon

doi: 10.1136/annrheumdis-2019-215922
Correspondence
Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter
Free

Nabiha Sbeih, Alexis Mathian, Marc Pineton de Chambrun, Raphael Lhote, Noël Zahr, Micheline Pha, Fleur Cohen-Aubart, Julien Haroche, Miguel Hié, Sophie Jouffroy, Neila Benameur, Hervé Devilliers, Zahir Amoura

doi: 10.1136/annrheumdis-2019-215732
Correspondence response
Response to: ‘Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis’ by Sugiyama
Free

Gulsen Ozen, Kaleb Michaud

doi: 10.1136/annrheumdis-2019-215775
Recommendation
EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases
Free

Laure Gossec, Joanna Kedra, Hervé Servy, Aridaman Pandit, Simon Stones, Francis Berenbaum, Axel Finckh, Xenofon Baraliakos, Tanja A Stamm, David Gomez-Cabrero, Christian Pristipino, Remy Choquet, Gerd R Burmester, Timothy R D J Radstake

doi: 10.1136/annrheumdis-2019-215694

July 05, 2019

Correspondence response
Response to: ‘Less antibiotics but no inferior effect for bacterial arthritis’ by Zhang et al
Free

Ilker Uçkay, Ergys Gjika

doi: 10.1136/annrheumdis-2019-215909
Correspondence
Is it currently reasonable to offer short, 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?
Free

Guillaume Coiffier, Marion Couderc, Raphaele Seror, Geraldine Bart, Christelle Darrieutort-Laffite, Benoit Le Goff

doi: 10.1136/annrheumdis-2019-215887
Correspondence response
Response to: ‘Is it currently reasonable to offer short 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?’ by Coiffier et al
Free

Ilker Uçkay, Amanda Gonzalez, Ergys Gjika

doi: 10.1136/annrheumdis-2019-215905
Correspondence
Less antibiotics but no inferior effect for bacterial arthritis
Free

Jian Tian, Chao Cheng, Fangjie Zhang

doi: 10.1136/annrheumdis-2019-215682

July 04, 2019

Correspondence response
Response to: ‘Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials’ by Lee and Song
Free

Wenhui Xie, Shiyu Xiao, Zhuoli Zhang

doi: 10.1136/annrheumdis-2019-215841
Correspondence response
Response to: ‘Can biomarkers differentiate psoriatic arthritis from osteoarthritis?’ by Tian et al
Free

Vinod Chandran, Richard J Cook, Dafna D Gladman

doi: 10.1136/annrheumdis-2019-215762
Correspondence response
Response to: ‘Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome’ by van den Hoogen et al
Free

Mariana J Kaplan, Kerry A Casey

doi: 10.1136/annrheumdis-2019-215811
Correspondence response
Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: ‘Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero’ by Satis et al
Free

Johannes Mofors, Sven-Erik Sonesson, Marie Wahren-Herlenius

doi: 10.1136/annrheumdis-2019-215677

July 03, 2019

Correspondence response
Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin
Free

Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215810
Correspondence
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations
Free

Giovanni Orsolini, Irene Elizabeth Maria Bultink, Giovanni Adami, Angelo Fassio, Ombretta Viapiana, Alessandro Giollo, Davide Gatti, Maurizio Rossini

doi: 10.1136/annrheumdis-2019-215896
Correspondence response
Response to: ‘Comment on editorial ‘Pathogenic effector functions of ACPA: where do we stand’’ by Holmdahl
Free

René Toes, David S Pisetsky

doi: 10.1136/annrheumdis-2019-215870

June 27, 2019

Correspondence response
Response to: ‘Can IL-1 be used as a target for osteoarthritis?’ by Cheng et al
Free

Margreet Kloppenburg, Marc Levesque

doi: 10.1136/annrheumdis-2019-215612

June 22, 2019

Correspondence
Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA
Free

Xanthe ME Matthijssen, Tom WJ Huizinga, Ellis Niemantsverdriet, Annette HM van der Helm-van Mil

doi: 10.1136/annrheumdis-2019-215843

June 21, 2019

Correspondence
On using machine learning algorithms to define clinically meaningful patient subgroups
Free

Iago Pinal-Fernandez, Andrew Lee Mammen

doi: 10.1136/annrheumdis-2019-215852
Correspondence
Comment on editorial ‘Pathogenic effector functions of ACPA: where do we stand?’
Free

Rikard Holmdahl

doi: 10.1136/annrheumdis-2019-215857

June 19, 2019

Correspondence response
Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al’ by Vandergheynst et al
Free

Rachel B Jones, Thomas F Hiemstra, Michael Walsh, David Jayne, Lorraine Harper

doi: 10.1136/annrheumdis-2019-215658

June 18, 2019

Correspondence
Association between ankylosing spondylitis and venous thromboembolism
Free

Shih-Wei Lai

doi: 10.1136/annrheumdis-2019-215854

June 05, 2019

Correspondence
Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine
Free

Martin Michaud, Florian Catros, Sophie Ancellin, Francis Gaches

doi: 10.1136/annrheumdis-2019-215799
Correspondence
Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Free

Íñigo Rua Figueroa, Celia Erausquin

doi: 10.1136/annrheumdis-2019-215778
Recommendation
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
Free

Pascal Richette, Michael Doherty, Eliseo Pascual, Victoria Barskova, Fabio Becce, Johann castaneda, Malcolm Coyfish, Sylvie Guillo, Tim Jansen, Hein Janssens, Frédéric Lioté, Christian D Mallen, George Nuki, Fernando Perez-Ruiz, José Pimentao, Leonardo Punzi, Anthony Pywell, Alexander K So, Anne-Kathrin Tausche, Till Uhlig, Jakub Zavada, Weiya Zhang, Florence Tubach, Thomas Bardin

doi: 10.1136/annrheumdis-2019-215315
Correspondence response
Antisynthetase antibodies in clinical laboratories: the importance of clinical correlation and indirect immunofluorescence
Free

Martin Greco, Mª Jesus García de Yébenes, Inmaculada Alarcón, Anahy María Brandy-García, Íñigo Rúa-Figueroa, Estibaliz Loza, Loreto Carmona

doi: 10.1136/annrheumdis-2019-215766

June 01, 2019

Correspondence
Can biomarkers differentiate psoriatic arthritis from osteoarthritis?
Free

Jian Tian, Chao Cheng, Fangjie Zhang

doi: 10.1136/annrheumdis-2019-215745

May 31, 2019

Correspondence
Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis
Free

Toshihiro Sugiyama

doi: 10.1136/annrheumdis-2019-215747

May 29, 2019

Correspondence
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone
Free

Maxime Samson, Bernard Bonnotte

doi: 10.1136/annrheumdis-2019-215697
Correspondence response
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson et al
Free

Christoph T Berger, Thomas Daikeler

doi: 10.1136/annrheumdis-2019-215729
Correspondence
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients
Free

Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone

doi: 10.1136/annrheumdis-2019-215715

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

July 13, 2019

July 12, 2019

July 11, 2019

July 08, 2019

July 05, 2019

July 04, 2019

July 03, 2019

June 27, 2019

June 22, 2019

June 21, 2019

June 19, 2019

June 18, 2019

June 17, 2019

June 14, 2019

June 12, 2019

June 08, 2019

June 05, 2019

June 01, 2019

May 31, 2019

May 29, 2019

Pages